Sustainability & Climate

A new hotel on Palm Jumeirah challenges Dubai's opulent norms with a vision of calm and efficiency, guided by its enigmatic founder, Yasam Ayavefe.

Pandora's 2025 growth slows amid weak consumer sentiment, but a new CEO plans a strategic reset to combat rising costs and boost brand desirability.

The semiconductor giant's stellar revenue, driven by a 19% surge in its core packaging business, confirms strong demand for AI and advanced tech.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

A major pharma giant is betting on artificial intelligence to accelerate cancer drug discovery, a move that could reshape the future of oncology treatment.

Belgian biotech MRM Health gets the green light for a Phase 2b trial of MH002, a novel 'living drug' aimed at revolutionizing ulcerative colitis care.

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

FieldBee Vision's gold medal win at LAMMA 2026 signals a new era of accessible, AI-driven precision agriculture for farms of all sizes.

Chery Australia's new campaign does more than sell cars; it aims to drive tourism to regional Australia and redefine the classic family road trip.

Ventyx Biosciences is under investigation for misleading investors after a trial delay caused a 15% stock drop, even as a pharma giant moves to acquire it.

With a new CEO from Illumina and Exact Sciences, Quanterix signals a strategic shift from tech development to aggressive market and clinical expansion.

From firefighting robots to AI health diagnostics, Hong Kong's record delegation at CES 2026 wins big, signaling its arrival as a global tech powerhouse.

As Copa Holdings prepares its Q4 2025 results, investors and analysts will scrutinize if the airline can sustain its stellar performance and margins.

Alessa Therapeutics’ rice-sized implant, Enolen, earns FDA Fast Track, promising a new era for prostate cancer therapy without debilitating side effects.

A massive co-investment targets 6,000 apartments in Atlanta and D.C. for upgrades, signaling institutional confidence and raising affordability questions.

The American Library Association marks its sesquicentennial with a year of celebration, highlighting its legacy and confronting a modern surge in censorship.

A new report reveals Canada's rail sector hit record safety, invested $4.5B, and grew its high-paying workforce, proving its essential economic role.

After 13 years of refining its model, the luxury hair extension salon is partnering with a top developer to launch its specialized concept nationwide.

Backed by Pfizer Ventures, Enodia Therapeutics' novel AI platform aims to stop diseases by degrading proteins at their source, a major shift in drug discovery.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.